![Dietmar Berger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dietmar Berger
Net worth: 1 M $ as of 30/12/2025
Profile
Dietmar P. Berger occupies the position of Chief Medical Officer & Global Head-Development at Sanofi. In his past career he held the position of Global Head-Research & Development at Atara Biotherapeutics, Inc., Head-Clinical Research Centre at Universitätsklinikum Freiburg, Vice President-Clinical Hematology & Oncology at Genentech, Inc. and Head-Clinical Research Centre at The Scripps Research Institute. Dr. Berger received a graduate degree and a doctorate from the University of Freiburg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/01/2026 | 9,382 ( 0% ) | 1 M $ | 30/12/2025 |
Dietmar Berger active positions
| Companies | Position | Start |
|---|---|---|
| INHIBRX, INC. | President | 29/05/2024 |
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/01/2025 |
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 05/02/2025 |
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Dietmar Berger
| Companies | Position | End |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/05/2019 |
Genentech, Inc.
 Genentech, Inc. Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 30/04/2018 |
| SANOFI | Chief Tech/Sci/R&D Officer | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Universitätsklinikum Freiburg
 Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Operates as a teaching hospital | Corporate Officer/Principal | - |
Training of Dietmar Berger
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. Operates as a biotechnology company that develops medicines for cancer peoples | |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universitätsklinikum Freiburg
Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Operates as a teaching hospital | Health Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | |
Inhibrx, Inc.
 Inhibrx, Inc. Operates as clinical-stage biotechnology company |
- Stock Market
- Insiders
- Dietmar Berger
